U.S. Stocks Have Now Fallen For 5 Weeks In A Row but Some Insiders are Buying

U.S. Stocks Have Now Fallen For 5 Weeks In A Row – That Is The Worst Stock Market Streak In Almost 8 Years but a Few Insiders Find Bargains Investor confidence is waning.  The Summer doldrums are…


Insider Selling Swamps Buying - Week Ending in May 4-2018

$DDR,$RDN,$FB,$GRMN,$ORCL,$MA,$NYT,$DOCU,$BMN,$PYPL,$CRM,$MASI,$ALXN In this report, we examine stocks that C-level officers and directors bought and sold ending the week of May 4, 2018. Insiders…


Fight Cancer Now $BMY

Today, Bristol announced that Opdivo (PD-1)/ Yervoy (CTLA-4) in CM- 214 study for 1L mRCC (kidney cancer) was stopped early after meeting its OS endpoint, ahead of Street’s expectations.  I think…


Cure Lung Cancer Now $BMY Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 - Goldman

Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 - GoldmanArticleGoldman Sachs maintained a Buy rating on Bristol-Myers Squibb Co. (NYSE: BMY) with a price target of…


What really happened today

Once the dust settles, pundits and analysts will begin to start calculating what we've been telling you all along.  Many, many blue chip stocks are dirt cheap based on discounted cash flow analysis…